antibiotic
Scientists discover powerful antibiotic using AI
Image copyright Getty Images In a world first, scientists have discovered a new type of antibiotic using artificial intelligence (AI). It has been heralded by experts as a major breakthrough in the fight against the growing problem of drug resistance. A powerful algorithm was used to analyse more than one hundred million chemical compounds in …
New gene technology shows 100-fold efficiency in targeting antibiotic-resistant bacteria
Taking advantage of powerful advances in CRISPR gene editing, scientists at the University of California San Diego have set their sights on one of society’s most formidable threats to human health. A research team led by Andrés Valderrama at UC San Diego School of Medicine and Surashree Kulkarni of the Division of Biological Sciences has …
Drug Pipeline To Fight Antibiotic Resistance Is Running Low : Shots
Pseudomonas aeruginosa bacteria — rod-shaped bacteria in this tinted, scanning electron microscope image — are found in soil, water and as normal flora in the human intestine. But they can cause serious wound, lung, skin and urinary tract infections, and many pseudomonas strains are drug-resistant. Science Photo Library/Science Source hide caption toggle caption Science Photo …
World Antibiotic Awareness Week 2019
Think twice. Seek advice. Each November, World Antibiotic Awareness Week (WAAW) aims to increase global awareness of antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance. Since their discovery, antibiotics have served as the cornerstone of modern …
New antibiotic approved for drug-resistant tuberculosis
(Jacquelyn Martin/AP) The Food and Drug Administration on Wednesday approved a new drug for highly drug-resistant tuberculosis, the world’s leading infectious cause of death. Tuberculosis kills 1.6 million people a year, about 500,000 of whom suffer from drug-resistant strains of the disease. The antibiotic, called pretomanid, was developed by a nonprofit group called TB Alliance …
